VC  Mesa Verde Venture Partners

     Office Locations:

2550 Fifth Ave., Suite 900
San Diego, CA 92103
Phone: 619-289-7428



  • Early



  • Life Sciences & Healthcare
  • Medical Device



    Mesa Verde Venture Partners is a life sciences venture capital fund founded in San Diego in 2006. Mesa Verde Venture Partners' charter is to invest in a diversified portfolio of early-stage biotechnology and medical technology companies in the Southwest. Areas of focus include drug discovery/ tools, medical devices and diagnostics, and healthcare information technology. Mesa Verde Venture Partners is the successor fund to IngleWood Ventures of San Diego. Sanderling is the lead investor behind Mesa Verde Venture Partners. The firm's preferred investment size is $250,000 to $1 million initially and up to $1.5 million per company over time.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Southern California Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Southern California Database subscription.
    Fred A. Middleton Managing Director


    Recent Funding Events (trailing 12 months):










      Series B


    Portfolio companies include:

        web link

      Biscayne Neurotherapeutics
        web link

      Exagen Diagnostics
        web link

        web link

        web link

        web link

        web link

      Paradigm Diagnostics
        web link

        web link

        web link



    Recent News: